Detail page

Knowledge Web

Person

Rosalind A. Eeles (1959-)

Name	Rosalind A. Eeles
Time	1959- (Date of birth and death)
Place	Großbritannien
Variant	Ros Eeles Rosalind Eeles
Related	Krebsforschung (Thema) Genetik (Thema)
Source	LCAuth
Record type	Person
GND-Identifier	172619688
Record ID	172619688
Involved in show all Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer Genomic evolution shapes prostate cancer disease type Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups Marital status and prostate cancer incidence: a pooled analysis of 12 case–control studies from the PRACTICAL consortium Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers Association analyses identify 31 new risk loci for colorectal cancer susceptibility Correction: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions Germline variation at 8q24 and prostate cancer risk in men of European ancestry Large-scale transcriptome-wide association study identifies new prostate cancer risk regions Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21 Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2mutation carriers Gene promoter hypermethylation in ductal lavage fluid from healthy BRCAgene mutation carriers and mutation-negative controls

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Rosalind A. Eeles (1959-)

Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer

Genomic evolution shapes prostate cancer disease type

Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer

Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects

Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups

Marital status and prostate cancer incidence: a pooled analysis of 12 case–control studies from the PRACTICAL consortium

Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

Association analyses identify 31 new risk loci for colorectal cancer susceptibility

Correction: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease

Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia

Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility

Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

Large-scale transcriptome-wide association study identifies new prostate cancer risk regions

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets

Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia

Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility

Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls

Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers

Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2mutation carriers

Gene promoter hypermethylation in ductal lavage fluid from healthy BRCAgene mutation carriers and mutation-negative controls